The science-based economy: The role of health research
Article
It is important we prioritise health research and development, including basic science, public health, behavioural science, and innovation development. The UK’s health sector has clear strengths. It has an enviable academic base, delivers strong return on investment, and is home to an exciting range of businesses with the potential to grow. As we build the role of science in our economy, health research and the life sciences should be a central pillar in our approach.
But we need a strategy to maximise gains. Health research and the life sciences can provide significant value – for our economy, society, and health. However, we will not maximise that value without a coherent strategy. The new 'R&D Roadmap' has begun that process for the research and development as a whole. However, we need to translate that into specific, bold strategies for strength R&D areas – like health and the life sciences.
This report outlines a progressive approach, based on three central pillars.
Related items
Taken to heart: Inequalities in heart disease in Scotland
More than 7.6 million people across the UK live with cardiovascular disease (CVD), around twice as many as live with Alzheimer’s disease and cancer combined.Skills passports: An essential part of a fair transition
This month, government will publish its Clean Energy Workforce Strategy. This plan covers two aims. First, filling the growing demand for skills in clean energy industries is essential to keep on track to reach the government’s clean power…Fixing the leak: How to end the £22 billion annual taxpayer losses at the Bank of England
The Bank of England increased its interest rates over recent years, aimed at reducing inflation. But this has also had an unintended effect on the Bank of England’s massive government bond buying – ‘quantitative easing’ – programme.